Two Blokes

Jiangsu Hengrui grants GSK global rights to drug portfolio in $500 million deal

  • click to rate
    Posted by Two Blokes Jul 28 - Filed in Stock - 4 views
    China's Jiangsu Hengrui Pharmaceuticals said on Monday it has agreed to license the global rights of its HRS-9821 drug and 11 other programmes to GlaxoSmithKline Intellectual Property (GSK) for $500 million upfront.